These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1070145

  • 1. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Endrenyl L, Kelly MF, Fenton SS.
    Scand J Infect Dis Suppl; 1976; (9):24-31. PubMed ID: 1070145
    [Abstract] [Full Text] [Related]

  • 2. Preliminary studies on the elimination of 3-H doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA, Johnson GE, Kelly MF, Fenton SS.
    Rev Can Biol; 1973; 32():Suppl:107-11. PubMed ID: 4777591
    [No Abstract] [Full Text] [Related]

  • 3. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE.
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [Abstract] [Full Text] [Related]

  • 4. [The pharmacokinetics of doxycycline in kidney insufficiency in geriatric patients compared to younger adults].
    Simon C, Malerczyk V, Engelke H, Preuss I, Grahmann H, Schmidt K.
    Schweiz Med Wochenschr; 1975 Nov 29; 105(48):1615-20. PubMed ID: 1215947
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of iopentol in patients with chronic renal failure.
    Svaland MG, Kolmannskog F, Lillevold PE, Nordal KP, Ressem L, Berg KJ.
    Acta Radiol; 1992 Sep 29; 33(5):482-4. PubMed ID: 1389660
    [Abstract] [Full Text] [Related]

  • 6. [Study, by means of a spectrofluorometric method, of plasma concentrations of doxycycline and of the elimination of this antibiotic in urine or dialysis fluid in patients with severe chronic kidney failure].
    Gavend M, Muller JM, Bessard G, Meftahi H, Debru JL, Cordonnier D.
    Therapie; 1972 Sep 29; 27(5):925-36. PubMed ID: 4651413
    [No Abstract] [Full Text] [Related]

  • 7. Urinary and fecal excretion of topotecan in patients with malignant solid tumours.
    Herben VM, Schoemaker nE, Rosing H, van Zomeren DM, ten Bokkel Huinink WW, Dubbelman R, Hearn S, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2002 Jul 29; 50(1):59-64. PubMed ID: 12111113
    [Abstract] [Full Text] [Related]

  • 8. Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function.
    Mahon WA, Wittenberg JV, Tuffnel PG.
    Can Med Assoc J; 1970 Nov 07; 103(10):1031-4. PubMed ID: 5494820
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G, Cavaliere G, D'Amico G, Passarella E, Broccali G.
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep 07; 23(9):491-6. PubMed ID: 4055162
    [Abstract] [Full Text] [Related]

  • 10. [Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].
    Słuczanowski W.
    Ann Acad Med Stetin; 1981 Sep 07; 27():313-30. PubMed ID: 7345952
    [No Abstract] [Full Text] [Related]

  • 11. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S.
    Drug Metab Dispos; 1996 Feb 07; 24(2):156-63. PubMed ID: 8742226
    [Abstract] [Full Text] [Related]

  • 12. Tritiated digoxin: studies in renal disease in human subjects.
    Doherty JE, Bissett JK, Kane JJ, de Soyza N, Murphy ML, Flanigan WJ, Dalrymple GV.
    Int J Clin Pharmacol Biopharm; 1975 Jul 07; 12(1-2):89-95. PubMed ID: 1100542
    [Abstract] [Full Text] [Related]

  • 13. Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis.
    Marc-Aurele J, Caille G, Bourgoin J.
    Sleep; 1987 Jul 07; 10 Suppl 1():22-6. PubMed ID: 3438644
    [Abstract] [Full Text] [Related]

  • 14. Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure.
    Hachisu T, Yokoyama T, Oda Y, Ando K, Hattori Y, Yoshida T.
    Clin Ther; 1988 Jul 07; 10(6):656-63. PubMed ID: 2905936
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
    Teichert J, Tuemmers T, Achenbach H, Preiss C, Hermann R, Ruus P, Preiss R.
    J Clin Pharmacol; 2005 Mar 07; 45(3):313-28. PubMed ID: 15703366
    [Abstract] [Full Text] [Related]

  • 16. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
    Haffner D, Schaefer F, Girard J, Ritz E, Mehls O.
    J Clin Invest; 1994 Mar 07; 93(3):1163-71. PubMed ID: 8132756
    [Abstract] [Full Text] [Related]

  • 17. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM, Kumana CR, Franklin DA, Baker LR.
    Int J Clin Pharmacol Biopharm; 1975 Jul 07; 12(1-2):83-8. PubMed ID: 1165145
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of nicotine in kidney failure.
    Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R.
    Clin Pharmacol Ther; 2000 Sep 07; 68(3):250-60. PubMed ID: 11014406
    [Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 07; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. Studies on the excretion of doxycycline in patients with ileostomies.
    Alestig K.
    Scand J Infect Dis Suppl; 1976 Nov 07; (9):20-3. PubMed ID: 1070144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.